Skip to main content

News Archive

News Archive - School of Medicine

Boosting Immune Cell Memory to Improve Vaccines and Cancer Immunotherapy

August 28, 2017

In mouse experiments, researchers at University of California San Diego School of Medicine have discovered that drugs that activate the cells’ proteasome, or recycling center, tip the balance in favor of memory CD8+ T cells. This approach could be used to improve how well vaccines and immunotherapies work and how long they last.

It’s Not a Rat’s Race for Human Stem Cells Grafted to Repair Spinal Cord Injuries

August 28, 2017

More than one-and-a-half years after implantation, researchers at University of California San Diego School of Medicine and the San Diego Veterans Administration Medical Center report that human neural stem cells (NSCs) grafted into spinal cord injuries in laboratory rats displayed continued growth and maturity, with functional recovery beginning one year after grafting.

Breakthrough Clinical Psychology Program Funded by UC San Diego Alumnus

August 25, 2017

Joseph Edelman, founder and CEO of life science-focused hedge fund Perceptive Advisors, feels that poor mental health affects not only one’s personal well-being, but that of those around them and the entire economy “because people are more productive when they’re happier.” Two years ago, this belief led him to donate $400,000 to increase mental health services to students at the University of California San Diego.

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

August 24, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

Help UC San Diego Scientists Study Link between Body Bacteria and Autoimmune Diseases

August 23, 2017

The public's help is being enlisted in the Microbiome Immunity Project, what's thought to be the biggest study to date of the human microbiome — the communities of bacteria and other microbes that live in and on the human body, where they influence our health.

GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed

August 18, 2017

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.

Prestigious Rankings Name UC San Diego 15th Best University in the World

August 15, 2017

The University of California San Diego has been ranked the 15th best university in the world by the 2017 Academic Ranking of World Universities (ARWU). UC San Diego was also named the world’s third best public college. The campus was named the world’s fourth best public college and nationally, UC San Diego was recognized as the country’s 13th best university.

New Study Reveals Public Resistance to Use of Genetically Engineered Mosquitoes for Disease Control

August 15, 2017

The study -- led by QI affiliate Cinnamon Bloss -- was published in today's edition of the Journal of the American Medical Association and suggests a strong resistance to the use of genetically engineered mosquitoes for controlling disease.

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

August 15, 2017

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

Qualcomm Institute’s CARI Therapeutics Awarded NIH Grant for Opioid Sensor

August 10, 2017

QI Innovation Space member CARI Therapeutics has received a grant from the National Institutes of Health to collaboratively develop a biosensor that will detect the presence of opioids in patients in recovery.
Category navigation with Social links